Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q1 2025 value amounting to $1.0 million.

  • Indivior Pharmaceuticals' Short-term Investments fell 9878.05% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.0 million, marking a year-over-year decrease of 9878.05%. This contributed to the annual value of $1.0 million for FY2024, which is 9975.9% down from last year.
  • According to the latest figures from Q1 2025, Indivior Pharmaceuticals' Short-term Investments is $1.0 million, which was down 9878.05% from $1.0 million recorded in Q4 2024.
  • Over the past 5 years, Indivior Pharmaceuticals' Short-term Investments peaked at $415.0 million during Q4 2023, and registered a low of $1.0 million during Q4 2024.
  • Its 4-year average for Short-term Investments is $103.8 million, with a median of $82.0 million in 2024.
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 24873.95% in 2023, then crashed by 9975.9% in 2024.
  • Over the past 4 years, Indivior Pharmaceuticals' Short-term Investments (Quarter) stood at $119.0 million in 2022, then soared by 248.74% to $415.0 million in 2023, then crashed by 99.76% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Its Short-term Investments was $1.0 million in Q1 2025, compared to $1.0 million in Q4 2024 and $30.0 million in Q3 2024.